Your browser doesn't support javascript.
loading
The Distress Thermometer for screening for severe fatigue in newly diagnosed breast and colorectal cancer patients.
Abrahams, H J G; Gielissen, M F M; de Lugt, M; Kleijer, E F W; de Roos, W K; Balk, E; Verhagen, C A H H V M; Knoop, H.
Afiliação
  • Abrahams HJG; Expert Center for Chronic Fatigue (ECCF), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gielissen MFM; Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • de Lugt M; Department of Medical Psychology, Hospital Gelderse Vallei, Ede, The Netherlands.
  • Kleijer EFW; Department of Education and Training, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Roos WK; Department of Surgery, Hospital Gelderse Vallei, Ede, The Netherlands.
  • Balk E; Department of Medical Oncology, Hospital Gelderse Vallei, Ede, The Netherlands.
  • Verhagen CAHHVM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Knoop H; Expert Center for Chronic Fatigue (ECCF), Radboud University Medical Center, Nijmegen, The Netherlands.
Psychooncology ; 26(5): 693-697, 2017 05.
Article em En | MEDLINE | ID: mdl-27362532
OBJECTIVE: Internationally, the Distress Thermometer and associated Problem List are increasingly used in oncology as screening tools for psychological distress. Cancer-related fatigue is common but often overlooked in clinical practice. We examined if severe fatigue in cancer patients can be identified with the fatigue item of the Problem List. METHODS: Newly diagnosed breast (N = 334) and colorectal (N = 179) cancer patients were screened for severe fatigue, which was defined as having a positive score on the fatigue item of the Problem List. The Fatigue Severity subscale of the Checklist Individual Strength was used as gold standard measure for severe fatigue. RESULTS: In total, 78% of breast cancer patients and 81% of colorectal cancer patients were correctly identified with the fatigue item. The sensitivity was 89% in breast cancer patients and 91% in colorectal cancer patients. The specificity was 75% in breast cancer patients and 77% in colorectal cancer patients. The positive predictive value was 53% in breast cancer patients and 64% in colorectal cancer patients, whereas the negative predictive value was 95% in both tumor types. CONCLUSIONS: The fatigue item of the Problem List performs satisfactorily as a quick screening tool for severe fatigue. However, a positive screen should be followed up with a more thorough assessment of fatigue, ie, a questionnaire with a validated cutoff point. Given time pressure of clinicians, this already implemented and brief screening tool may prevent severe fatigue from going undetected in clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Neoplasias da Mama / Neoplasias Colorretais / Fadiga Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Neoplasias da Mama / Neoplasias Colorretais / Fadiga Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article